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The Medical Research Council grading system has served through decades for the evaluation of muscle strength and has been
recognized as a cardinal feature of daily neurological, rehabilitation and general medicine examination of patients, despite being
respectfully criticized due to the unequal width of its response options. No study has systematically examined, through modern
psychometric approach, whether physicians are able to properly use the Medical Research Council grades. The objectives of this
study were: (i) to investigate physicians’ ability to discriminate among the Medical Research Council categories in patients with
different neuromuscular disorders and with various degrees of weakness through thresholds examination using Rasch analysis
as a modern psychometric method; (ii) to examine possible factors inﬂuencing physicians’ ability to apply the Medical Research
Council categories through differential item function analyses; and (iii) to examine whether the widely used Medical Research
Council 12 muscles sum score in patients with Guillain–Barre ´ syndrome and chronic inﬂammatory demyelinating polyradiculo-
neuropathy would meet Rasch model’s expectations. A total of 1065 patients were included from nine cohorts with the fol-
lowing diseases: Guillain–Barre ´ syndrome (n = 480); myotonic dystrophy type-1 (n = 169); chronic inﬂammatory demyelinating
polyradiculoneuropathy (n = 139); limb-girdle muscular dystrophy (n = 105); multifocal motor neuropathy (n = 102); Pompe’s
disease (n = 62) and monoclonal gammopathy of undetermined related polyneuropathy (n = 8). Medical Research Council data
of 72 muscles were collected. Rasch analyses were performed on Medical Research Council data for each cohort separately and
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patients with Guillain–Barre ´ syndrome and chronic inﬂammatory demyelinating polyradiculoneuropathy. Disordered thresholds
were demonstrated in 74–79% of the muscles examined, indicating physicians’ inability to discriminate between most Medical
Research Council categories. Factors such as physicians’ experience or illness type did not inﬂuence these ﬁndings. Thresholds
were restored after rescoring the Medical Research Council grades from six to four options (0, paralysis; 1, severe weakness;
2, slight weakness; 3, normal strength). The Medical Research Council sum score acceptably fulﬁlled Rasch model expectations
after rescoring the response options and creating subsets to resolve local dependency and item bias on diagnosis. In conclusion,
a modiﬁed, Rasch-built four response category Medical Research Council grading system is proposed, resolving clinicians’
inability to differentiate among its original response categories and improving clinical applicability. A modiﬁed Medical
Research Council sum score at the interval level is presented and is recommended for future studies in Guillain–Barre ´ syndrome
and chronic inﬂammatory demyelinating polyradiculoneuropathy.
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Introduction
In 2005, a historical essay tracing the history of scoring and sum-
mation of neuromuscular weakness as part of daily neurological
practice was published by Dyck et al. (2005). Mitchell and Lewis
(1886) initiated the practice of alphanumerical scoring of neuro-
logical signs in the 19th century. However, it was Lovett, an
orthopaedic surgeon, who introduced an ordinal scoring of
muscle weakness that formed the basis for the Mayo Clinics and
Medical Research Council (MRC) manual muscle testing grading
systems, of which the MRC system is most widely used (Medical
Research Council, 1943; Dyck et al., 2005). Its worldwide recog-
nition is most probably due to its simplicity, and drawings illustrat-
ing how limb muscles should be tested. Through the decades,
various versions have been published that aimed to improve the
methods for muscle examination. The 2010 edition of Aids to the
Investigation of Peripheral Nerve Injuries. Medical Research
Council: Nerve Injuries Research Committee was recently pre-
sented on behalf of the guarantors of Brain, embracing a historical
review and appreciation for its nurtures through the decades
(Compston, 2010). Despite being the most cardinal feature of
daily neurological practice, the MRC scale has been respectfully
criticized due to the unequal width of its categories, with Grades
1, 2 and 3 being too narrow, and 4 being too broad, often leading
to attempts to modify the scale (Brandsma et al., 1995; Dyck
et al., 2005; Cuthbert and Goodheart, 2007; MacAvoy and
Green, 2007; Merlini, 2010).
One of the most common sources of improper use of any out-
come measure concerns the inconsistent use of the response op-
tions that correspond to the scales’ items (Tennant and Conaghan,
2007). This results in what is known as ‘reversed or disordered
thresholds’. The term threshold refers to the point between two
adjacent response categories where either response is equally
probable. In the case of the MRC scale, a threshold would be
the point between two adjacent categories, such as between
MRC Grades 2 and 3. Disordered thresholds occur when phys-
icians have difﬁculty consistently discriminating between the MRC
grades in patients with various degrees of muscle weakness.
Surprisingly, no study has systematically examined the
appropriateness of the MRC scale using modern psychometric
techniques.
The objectives of this study were: (i) to examine the applicability
and discriminative capacity of physicians using the MRC grades in
patients with various neuromuscular illnesses with different
degrees of muscle weakness. We questioned whether physicians
could demonstrate a fairly uniform MRC grades’ ordered thresh-
olds pattern along the Rasch scale continuum, since previous
reports suggested human’s inability to differentiate between
more than four response options (Andrich, 1996; Penta et al.,
2001); (ii) to investigate the inﬂuence of factors possibly affecting
the proper use of the MRC grades in clinical practice (such as phys-
ician’s clinical experience). For these two objectives, the Rasch
method as a modern psychometric vehicle was used, solely focus-
ing on threshold and item bias examinations (Rasch, 1960;
Tennant and Conaghan, 2007); and (iii) since Guillain–Barre ´ syn-
drome and chronic inﬂammatory demyelinating polyradiculoneuro-
pathy (CIDP) are potentially treatable illnesses and the MRC sum
score has been often used as an outcome measure to determine
efﬁcacy in these illnesses, we have chosen to examine whether
this multi-item scale would fulﬁl all Rasch model expectations in
patients with Guillain–Barre ´ syndrome and CIDP and if not, to
propose changes to improve its use (Kleyweg et al., 1991; van
der Meche and Schmitz, 1992; Merkies, 2001; van Koningsveld
et al., 2004; Hughes et al., 2008)
Patients and methods
Patients
The MRC grades of various muscles were collected from different
neuromuscular seminal studies published in the last two decades.
Most of these studies have guided the worldwide neurological
community in understanding the clinical and therapeutic pattern
of these illnesses. A total of 1065 patients (Guillain–Barre ´ syn-
drome: n = 480; myotonic dystrophy type 1: n = 169; CIDP:
n = 139; limb-girdle muscular dystrophy: n = 105; multifocal
motor neuropathy: n = 102; Pompe’s disease: n = 62; and
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signiﬁcance: n = 8) were included (Table 1 and Supplementary
Table 1) (van der Meche ´ and Schmitz, 1992; van der Kooi
et al., 1996; de Die-Smulders et al., 1998; Van den Berg-Vos
et al., 2002; van Koningsveld et al., 2004; Hagemans et al.,
2005; Van Asseldonk et al., 2005; Hughes et al., 2008;
Hermans et al., 2010). The initial MRC data of all patients from
the above-mentioned cohorts were selected for the purposes of
the current study. All patients met their international criteria for
their illness (Asbury and Cornblath, 1990; AANA, 1991; Bushby
and Beckmann, 1995; Hirschhorn and Reuser, 2001; EFNS/PNS,
2006; Prior, 2009). The diagnosis ‘monoclonal gammopathy
related polyneuropathy of undetermined signiﬁcance’ was estab-
lished after excluding all possible causes for the gammopathy and
polyneuropathy (Miescher and Steck, 1996). For all studies, con-
sent was obtained according to the Declaration of Helsinki and
approval was obtained by the Ethical Committee of the institution
in which the original study was performed.
Assessment scale
The MRC grading system provides the following grades: 0, par-
alysis; 1, only a trace or ﬂicker of muscle contraction is seen or
felt; 2, muscle movement is possible with gravity eliminated; 3,
muscle movement is possible against gravity; 4, muscle strength is
reduced, but movement against resistance is possible and 5,
normal strength.
The MRC grades of the following six muscle pairs comprise the
MRC sum score for Guillain–Barre ´ syndrome and CIDP: upper arm
abductors, elbow ﬂexors, wrist extensors, hip ﬂexors, knee exten-
sors and foot dorsal ﬂexors (Kleyweg et al., 1991). In the remain-
ing cohorts (monoclonal gammopathy of undetermined
signiﬁcance related polyneuropathy, multifocal motor neuropathy,
mytonic dystrophy type-1, Pompe’s disease and limb-girdle mus-
cular dystrophy), the muscles groups evaluated represented the
clinical picture of each illness (see Supplementary Table 1 for avail-
able muscles per cohort).
Rasch analysis
Rationale for using Rasch method
In health care, outcome measures often consist of ordinal
multi-item questionnaires, based on the classical test theory
(DeVellis, 2006). Concerns have been raised about inappropriate
analysis of the generated summed scores that are erroneously
assumed to be at the interval level (Wright, 1999; Svensson,
2001; DeVellis, 2006). The ability of a scale to provide fundamen-
tal measurements should be established before the more com-
monly reported psychometric attributes such as being simple,
valid, reliable and responsive (Tennant et al., 2004a; Tennant
and Conaghan, 2007). Modern scientiﬁc methods have been
adopted to overcome the shortcomings of traditional measure-
ments. One of the most widely used modern techniques is the
Rasch method that transforms ordinal obtained scores into
interval-level variables, and whose ﬁt of data satisﬁes numerous
checkpoints as part of model expectations (Rasch, 1960; Tennant
et al., 2004a; Tennant and Conaghan, 2007).
In the current study setting, the Rasch model assumes that a
patient with less weakness (thus more strength) will have a greater
chance of receiving a higher MRC grade by the examining phys-
ician. A comprehensive description of the Rasch analysis speciﬁc-
ally for neurologists is provided elsewhere (Pallant and Tennant,
2007; Tennant and Conaghan, 2007; van Nes et al., 2011).
Brieﬂy, the Rasch model shows what should be expected in re-
sponse to ordinal items if interval scaling is to be achieved. For
this, the following criteria should be fulﬁlled.
(i) Thresholds examination: when using items with more than
two response categories, as for the MRC grades, proper
ordering of the response options should be veriﬁed using
category probability curves for each muscle group exam-
ined, since this will reﬂect the ability of physicians to use
the MRC in a correct way (Shaw et al., 1992). Ordered
thresholds are where the transition (threshold) between
categories map on to the underlying construct in the
expected manner. Thus the transition between categories
Table 1 Basic characteristics of patients with neuromuscular disorders
Study/disorder Patients
examined
(n)
Age, mean
years (SD),
range
Gender Symptoms duration,
mean (SD),
range (years) Female (%) Male (%)
INCAT study 113 54.3 (15.1), 14–84 54 (47.8) 59 (52.2) 6.9 (3.1), 0.5–28
Dutch Guillain–Barre ´ syndrome trial, 1992 147 47.5 (19.2), 5–81 71 (48.3) 76 (51.7) –
Dutch Guillain–Barre ´ syndrome trial, 2004 +
Guillain–Barre ´ syndrome pilot study, 1994
250 50.5 (20.1), 7–89 109 (43.6) 141 (56.4) –
Myotonic dystrophy type-1 169 43.5 (11.5), 18–69 83 (49.1) 86 (50.9) 5.3 (6.9), 0–34
Multifocal motor neuropathy 102 54.3 (12.1), 26–79 76 (74.5) 26 (25.5) 11.8 (8.2), 0.2–43
Pompe’s disease 62 48.1 (11.9), 25.1–71.7 29 (46.8) 33 (53.2) 7.9 (9.3), 0–30.5
Limb-girdle muscular dystrophy 105 37.8 (15.6), 3–70 64 (61.0) 41 (39.0) 21.0 (14.5), 0–58
ICE CIDP 117 51.6 (16.5), 18–83 40 (34.2) 77 (65.8) 5.3 (6.2), 0.2–34.3
In the INCAT studies, a total of 113 patients were examined (Guillain–Barre ´ syndrome, n = 83; CIDP, n = 22 and monoclonal gammopathy-related polyneuropathy of
undetermined signiﬁcance, n =8 ) .
ICE CIDP = immune globulin intravenous for CIDP; INCAT = inﬂammatory neuropathy cause and treatment.
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strength (Fig. 1, top). Disordered thresholds can occur
when physicians use the response options inconsistently,
and this inconsistency can be a source of misﬁt to model
expectations. The difﬁculty discriminating between response
options may be a result of too many options, or where the
labelling of the options is confusing, both of which may
lead to misinterpretation.
(ii) Fit statistics: ﬁt statistics give an indication of how well the
items ﬁt the expected ordering required by the model. This
ordering is a probabilistic version of Guttman Scaling
(Guttman, 1950). There are two general categories for
detecting misﬁt: overall (summary) misﬁt, using the entire
response matrix, and the individual ﬁt (examining all items
and all persons individually). At the summary level the
overall mean residual values for both persons and items
can be calculated. These values are expressed as a
z-score with a mean of 0 and a SD of 1, values of
which indicate perfect ﬁt to model expectations (Tennant
et al., 2004b; Pallant and Tennant, 2007). The summary
item–trait interaction statistic reﬂects the ﬁt of the
observed data to the model’s expectations and is repre-
sented by the chi-square. This statistic gives an indication
of the invariance of the ordering of items across patients
with different levels of muscle strength. A signiﬁcant chi-
square indicates a failure to retain this ordering. Besides
the overall ﬁt residuals, individual item–chi square and
item and person residuals can be calculated (Tennant
et al., 2004b; Pallant and Tennant, 2007; Vandervelde
et al., 2007).
(iii) Item bias: response to an item should not vary between
groups (e.g. males versus females), given the same level of
the underlying trait (e.g. muscle strength). We assessed item
bias (differential item functioning) on the MRC data for vari-
ous available person factors. A panel (I.S.J.M. and C.G.F.)
have studied the range of the factors age, disease duration
Figure 1 MRC response categories related thresholds explained and coded as ‘normal’ (green) or ‘abnormal’ (red)’. The ﬁrst row
shows the ideal graph representation for proper thresholds for the MRC grades. The ﬁrst threshold at the intersection between MRC
response options 0 and 1 corresponds to a 50% chance of choosing between these two adjacent categories. The thresholds should
be ordered to obtain an ideal graph: Threshold 15Threshold 25Threshold 35Threshold 45Threshold 5. The second and third row
give graphical examples of proper threshold ordering (coded as a green box) and disordered threshold (coded as a red box), respectively.
T1–T5 = Thresholds 1–5, respectively.
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Subsequently, these factors were categorized into subgroups
for item bias analyses, aiming for an equivalent distribution
of participants among the subgroups (25–33% per
subgroup).
(iv) Local dependency: local dependency arises when items are
linked such that the response on one item is dependent
upon the response to another. Item sets with correlations
40.3 are considered a source of misﬁt to the model
(Tennant and Conaghan, 2007).
(v) Unidimensionality: the Rasch model assumes unidimension-
ality and consequently post hoc tests are included in the
analysis to ensure that this assumption holds. These tests
involve a comparison of person estimates (of muscle
strength) based upon two sets of items identiﬁed from the
ﬁrst principal component analysis of the residuals. The esti-
mates for every individual are compared by a t-test, and
where 55% of these comparisons are signiﬁcantly different,
this is taken to support the assumption of unidimensionality
(Smith, 2002).
Test procedure
Figure 2 presents a systematic ordering of the analyses performed
in the current study. In Analyses 1 and 2 (MRC Rasch analyses for
each cohort separately and MRC Rasch analyses after pooling
data) the following were examined:
Step 1: the presence of ordered thresholds, thus determining
whether the MRC grades for each muscle were ordered reﬂect-
ing physicians’ ability to use these grades properly;
Step 2: in case of disordered thresholds: to seek for the most
optimal modiﬁed MRC rescored categories that could serve as
a uniﬁed tool in manual muscle scoring for all muscle groups. In
order to rescore the MRC categories, the frequency distribution
among the categories and the category probability curves were
taken into account;
Step 3: the presence of possible item bias was examined to de-
termine whether factors such as physician’s experience in the
neuromuscular ﬁeld (i.e. would a more experienced physician
apply the MRC grades more appropriately than a less experi-
enced physician?) or possible differences between community
and university based neurologists might inﬂuence the applicabil-
ity of the MRC grades.
Therefore, in Analyses 1 and 2, the Rasch method was applied
only to examine the ability of physicians to use the MRC grading
system in a proper way and to determine whether there were
factors inﬂuencing its use. These analyses were not intended to
create a formal Rasch-built MRC sum score for each cohort
Figure 2 Study algorithm showing a systematic ordering of the analyses performed in the current study. First analyses (Analysis 1): initial
MRC Rasch analysis for each individual cohort separately (thus performing a total of eight individual model analyses). Second analyses
(Analysis 2): MRC Rasch analyses after pooling data at the muscle level from available cohorts. Third analyses (Analysis 3): MRC sum score
Rasch analysis in patients with Guillain–Barre ´ syndrome and CIDP. DM1 = myotonic dystrophy type-1; ICE = immune globulin intravenous
for CISP; INCAT = inﬂammatory neuropathy cause and treatment; LGMD = limb-girdle muscular dystrophy; MMN = multifocal motor
neuropathy.
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small, hence not fulﬁlling the basic requirements for proper
Rasch modelling (Linacre, 1994).
For Analysis 2, MRC data were pooled at the muscle level from
the various available cohorts and resubjected to Rasch analysis,
thereby controlling for diagnosis as a possible confounder and
strengthening the category frequencies for the various muscles
(Linacre, 2002).
In Analysis 3 (MRC sum score Rasch analysis in Guillain–Barre ´
syndrome/CIDP), the MRC 12 muscles sum score was analysed to
determine whether Rasch model expectations would be met. The
ﬁrst two steps for Analyses 1 and 2 (see above) were also per-
formed here. Subsequently, since there is no consensus regarding
a ﬁxed sequence of steps that must be followed when doing Rasch
analyses, our rationale for the following steps were constantly driven
by the biggest abnormality seen when studying all subjected data to
Rasch, thereby focusing on all aspects that did not meet model
expectations (misﬁt statistics, ﬁt residuals disturbances, under-/over-
ﬁtting, local dependency 40.3, and item bias). All steps needed
were taken to create a unidimensional scale at the interval level.
Rasch general aspects, person factors
and statistics
The MRC data of each muscle group were treated as if it was an
‘item’ that needed to be completed by the patients with response
options from 0 to 5 (in the current study setting: a physician
completed the ‘item’) using the Rasch Unidimensional
Measurement Model 2020 software (Andrich et al., 2003).
In Analysis 1 (MRC Rasch in each cohort separately), the fol-
lowing person factors were taken into account (Supplementary
Table 2):
(i) Ages: 1, 540years; 2, 40–59years and 3, 560years;
(ii) gender: 0, female; 1, male;
(iii) type of disease: (a) inﬂammatory neuropathy-cause-and-
treatment cohort: 1, Guillain–Barre ´ syndrome; 2, CIDP; 3,
gammopathy related polyneuropathy; (b) myotonic dystrophy
cohort: 1, mild; 2, adult; 3, child/congenital type; and (c)
limb-girdle dystrophy cohort: 1, sarcoglycanopathy; 2, calpai-
nopathy; 3, limb-girdle type 1B, 2B and 2I; 4, unclassiﬁed;
(iv) duration of disease: (a) for all cohorts except limb-girdle
patients: 1, 55years; 2, 5–9years; 3, 10–19years; 4,
520years; and (b) for limb-girdle cohort: 1, 510years; 2,
10–19years; 3, 20–29years; 4, 530years;
(v) physician’s experience in the neuromuscular ﬁeld: for the
inﬂammatory–neuropathy cause and treatment studies: 1,
53years experience; 2, 3–5years experience; 3, 56years
experience; the latter group constituting senior neuromuscu-
lar experts;
(vi) institution; for the Guillain–Barre ´ syndrome trials: 0, commu-
nity based; 1, university based hospital; and
(vii) country; for the Guillain–Barre ´ syndrome cohort 2004: 1,
The Netherlands; 2, Germany; 3, Belgium.
For Analyses 2 and 3 (MRC Rasch after pooling data and MRC
sum score in Guillain–Barre ´ syndrome/CIDP), the factors studied
included (i) age category: 1, 540years; 2, 40–59years; 3, 560
years; (ii) gender: 0, female; 1, male; and (iii) type of disease:
depending on the amount of illnesses being pooled together,
each illness received a separate code.
For the MRC sum score analysis, the person separation index
was also determined, which should be 50.7 for proper group
comparison, and a minimum of 0.9 for clinical use (Bland and
Altman, 1997). The unrestricted partial credit Rasch model was
used. Further analyses were undertaken using Stata 11.0 statistical
software for Windows XP.
Results
General aspects
A total of 1065 patients with various neuromuscular disorders
were included from nine studies. Table 1 presents the patients’
characteristics. MRC data on 72 muscle groups were available
(Supplementary Table 1, muscle groups assessed per cohort).
Analysis 1: initial MRC Rasch analyses
for each cohort separately
Step 1: thresholds examination
The obtained data (ordered thresholds coded ‘green’; disordered
coded ‘red’; see Fig. 1 explaining these codes) for each muscle
group in each cohort were summed, thereby creating a total of
210 muscle groups examined. A total of 165 (78.6%) muscle
groups had disordered thresholds versus 45 (21.4%) with ordered
thresholds. The disordered thresholds were particularly seen in the
mid-response MRC category area (options 2 to 4).
Step 2: rescoring MRC categories
A panel of neuromuscular and Rasch researchers studied the cat-
egory probability curves and category frequencies of the MRC
data for each muscle group. Subsequently, all muscle groups
were systematically rescored in order to obtain the maximum uni-
form amount of response options, which turned out to be four
categories (instead of six). Of the 210 muscle groups rescored,
182 (86.7%) had ordered thresholds and 28 (13.3%) were still
disordered. Sixteen of these disordered muscle groups were distally
located (ﬁnger spreaders, ﬂexors and extensors, grip strength,
wrist extensors and ﬂexors, foot dorsal and plantar ﬂexors). All
disordered muscle groups except two were found in the two co-
horts with the lowest number of patient’s records (multifocal
motor neuropathy, n = 102 and Pompe’s disease, n = 62).
Step 3: item bias examination
Eight selected person factors were used to examine possible item
bias on the available muscle groups (see Supplementary Table 2
for available factors per cohort). Before rescoring, a total of 806
muscle groups (96.9%) were free of item bias, thus not being
inﬂuenced by person factors like physicians’ experience. Item
bias was only found in 26 muscles (3.1%; on person factor
gender: 11 muscle groups had uniform differential item
1644 | Brain 2012: 135; 1639–1649 E. K. Vanhoutte et al.Table 2 Results before and after rescoring the response options from six to four categories with corresponding threshold
locations
Studies
(n)
Pooling MRC data
per muscle group
Before
rescoring
After
rescoring
Thresholds location
Patients examined (n) Threshold 1 Threshold 2 Threshold 3
Face, neck and trunk muscles Face, neck and trunk muscles
Neck ﬂexors 3 336 Normal Normal 3.264 1.114 4.919
Neck extensors 3 336 Abnormal Normal 4.159 0.561 1.952
Sternocleidomastoid (right) 2 167 Abnormal Normal 7.343 2.472 0.074
Sternocleidomastoid (left) 2 167 Abnormal Normal 7.356 2.429 0.013
Trapezius (right) 2 167 Abnormal Normal 0.748 1.642 2.459
Trapezius (left) 2 167 Abnormal Normal 0.487 1.762 2.452
Pectoralis (right) 2 167 Abnormal Normal 1.001 1.644 4.24
Pectoralis (left) 2 167 Abnormal Normal 1.059 1.475 4.281
Masseter (right) 1 105 Abnormal Abnormal
Masseter (left) 1 105 Abnormal Abnormal
Infraspinatus (right) 1 105 Abnormal Normal 0.448 2.754 6.063
Infraspinatus (left) 1 105 Abnormal Normal 0.169 2.354 6.142
Rhomboid (right) 1 105 Abnormal Normal 0.001 3.012 7.695
Rhomboid (left) 1 105 Abnormal Normal 0.028 2.819 7.72
Back extensor muscles 1 105 Abnormal Normal 1.819 2.858 11.714
Latissimus dorsi (right) 1 105 Abnormal Normal 0.637 2.691 11.909
Latissimus dorsi (left) 1 105 Abnormal Normal 0.442 3.143 11.904
Abdominal muscles 1 105 Abnormal Normal 1.894 2.611 11.872
Upper extremity muscles Upper extremity muscles
Shoulder abductors (right) 7 1062 Abnormal Normal 3.232 0.683 2.643
Shoulder abductors (left) 7 1062 Abnormal Normal 2.99 0.727 2.668
Arm exorotation (right) 1 62 Abnormal Normal 7.252 0.432 7.684
Arm exorotation (left) 1 62 Abnormal Normal 7.247 0.442 7.689
Shoulder adductors (right) 1 62 Abnormal Normal 6.99 0.293 7.283
Shoulder adductors (left) 1 62 Abnormal Normal 6.984 0.307 7.291
Elbow ﬂexors (right) 7 1062 Abnormal Normal 3.454 0.441 2.672
Elbow ﬂexors (left) 7 1062 Abnormal Normal 3.212 0.547 2.526
Elbow extensors (right) 4 438 Abnormal Normal 4.118 1.027 2.926
Elbow extensors (left) 4 438 Normal Normal 4.038 1.258 2.796
Wrist extensors (right) 7 1062 Abnormal Normal 3.015 0.267 2.66
Wrist extensors (left) 7 1062 Abnormal Normal 3.471 0.348 2.685
Wrist ﬂexors (right) 3 269 Normal Normal 5.606 1.149 2.615
Wrist ﬂexors (left) 3 269 Abnormal Normal 4.333 0.368 2.159
Brachioradial (right) 1 105 Abnormal Normal 3.236 0.691 3.532
Brachioradial (left) 1 105 Abnormal Normal 3.51 0.128 3.189
Pronator (right) 1 105 Abnormal Normal 3.595 0.29 6.767
Pronator (left) 1 105 Abnormal Normal 3.521 0.383 6.771
Supinator (right) 1 105 Abnormal Normal 3.905 0.966 6.373
Supinator (left) 1 105 Abnormal Normal 3.865 0.707 6.399
Grip (right) 2 167 Abnormal Normal 7.509 4.424 3.069
Grip (left) 2 167 Abnormal Normal 7.284 4.55 2.852
Finger extensors (right) 3 269 Abnormal Normal 2.376 1.097 3.475
Finger extensors (left) 3 269 Abnormal Normal 2.704 0.378 3.38
Fingers spreaders (right) 3 269 Abnormal Normal 3.185 0.76 5.329
Finger spreaders (left) 3 269 Abnormal Normal 3.459 1.21 4.993
Finger ﬂexors (right) 3 376 Normal Normal 5.181 0.236 5.701
Finger ﬂexors (left) 3 376 Normal Normal 5.462 0.064 5.114
Thumb abductor (right) 1 102 Abnormal Normal 0.216 2.122 4.752
Thumb abductor (left) 1 102 Abnormal Normal 0.79 2.448 5.209
Thumb adductor (right) 1 102 Normal Normal 4.886 0.752 3.575
Thumb adductor (left) 1 102 Abnormal Normal 3.942 0.016 3.38
Opponens pollicis (right) 1 102 Abnormal Normal 4.834 0.631 3.836
Opponens pollicis (left) 1 102 Abnormal Normal 4.623 0.423 3.89
(continued)
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ation: two uniform and one non-uniform, on physician’s experi-
ence: two uniform, on country: one uniform, and on age: one
muscle group had uniform differential item functioning).
Differential item functioning ﬁndings did not change after rescor-
ing at the individual cohort level.
Analysis 2: MRC Rasch analyses after
pooling data
Step 1: thresholds examination
Similar ﬁndings were seen in the pooled data analyses. Of the 72
muscles examined, a total of 53 muscle groups (73.6%) had dis-
ordered threshold, particularly in the mid-categories (Table 2,
‘before rescoring’).
Step 2: rescoring MRC categories
Equivalent to the ﬁndings of Analysis 1 and based on the location
seen of the disordered thresholds (mid-categories 2–4), all muscle
groups were systematically rescored to a modiﬁed MRC with four
categories. Table 2 provides the data for the rescored MRC cate-
gories (see last four columns). Ordered thresholds were restored
for all muscles except the masseter muscle. A modiﬁed version of
the MRC grading system was created for clinical use with the
following grades: 0, paralysis; 1, severe weakness (deﬁned as
450% loss of strength); 2, slight weakness (550% loss of
strength); and 3, normal strength. A 50% cut-off was based on
the following: having four modiﬁed response options as having
three thresholds (three theoretical intersections between adjacent
response options: Thresholds 1, 2 and 3); half of the distance
between Threshold 3 (representing the intersection between mod-
iﬁed MRC Grades 2 and 3; location 4.3 logits) and Threshold 1
(intersection between modiﬁed grades 0 and 1; location 2.98)
for all 72 muscle groups is located at 0.66 logits [2.98 (location
Threshold 1) + 0.5  7.28 (0.5  distances between Threshold 3
and Threshold 1)], which is close to the mean for Threshold 2
(intersection between the modiﬁed Grades 1 and 2): 0.46.
Step 3: item bias examination
Differential item functioning was also performed on person factors
age, gender and diagnosis (Supplementary Table 3). Item bias was
hardly seen on age and gender. On diagnosis, 33 muscle groups
(45.8%) demonstrated differential item functioning
(Supplementary Table 3).
Analysis 3: MRC sum score Rasch
analysis in patients with Guillain–Barre ´
syndrome and chronic inﬂammatory
demyelinating polyradiculoneuropathy
Step 0: general description of patients examined and
initial ﬁndings
A total of 619 patients from several cohorts [Guillain–Barre ´
syndrome, n = 480; CIDP, n = 139; n = 272 females (43.9%)
and n = 347 males (56.1%)] were available for these analyses
Table 2 Continued
Studies
(n)
Pooling MRC data
per muscle group
Before
rescoring
After
rescoring
Thresholds location
Patients examined (n) Threshold 1 Threshold 2 Threshold 3
Lower extremity muscles Lower extremity muscles
Gluteus (right) 2 167 Normal Normal 2.21 1.781 5.175
Gluteus (left) 2 167 Normal Normal 2.2 1.703 5.337
Hip ﬂexors (right) 7 1062 Normal Normal 2.394 0.152 3.055
Hip ﬂexors (left) 7 1062 Normal Normal 2.295 0.076 3.045
Hip abductors (right) 2 167 Normal Normal 2.295 0.681 4.134
Hip abductors (left) 2 167 Normal Normal 2.299 0.663 4.214
Hip adductors (right) 2 167 Abnormal Normal 0.038 2.138 5.434
Hip adductors (left) 2 167 Abnormal Normal 0.135 2.223 5.418
Knee ﬂexors (right) 4 438 Normal Normal 1.333 0.92 4
Knee ﬂexors (left) 4 438 Normal Normal 1.3 0.795 4.156
Knee extensors (right) 7 1062 Normal Normal 2.721 0.418 2.064
Knee extensors (left) 7 1062 Normal Normal 2.739 0.381 2.052
Foot dorsal ﬂexors (right) 7 1062 Abnormal Normal 1.589 1.463 3.013
Foot dorsal ﬂexors (left) 7 1062 Abnormal Normal 1.578 1.408 3.093
Foot plantar ﬂexors (right) 4 438 Normal Normal 4.278 0.166 3.273
Foot plantar ﬂexors (left) 4 438 Abnormal Normal 4.218 0.339 3.209
Toes extensors (right) 2 207 Abnormal Normal 2.459 0.21 2.048
Toes extensors (left) 2 207 Abnormal Normal 2.271 0.003 2.474
Toes ﬂexors (right) 1 102 Abnormal Normal 4.328 0.921 2.41
Toes ﬂexors (left) 1 102 Abnormal Normal 4.194 0.954 2.497
A normal threshold ordering of the MRC grades is coded as ‘normal’; abnormal threshold is ‘abnormal’. See Fig. 1, for examples, explaining these codes. Threshold
location = location of the thresholds of adjacent MRC response options located on the created ruler (and expressed in logits).
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drome study group, 1994; Merkies, 2001; van Koningsveld et al.,
2004; Hughes et al., 2008). The original MRC summed score
failed to meet the model expectations. Misﬁt statistical ﬁndings
for all three statistical parameters were initially seen (Table 3, ‘ini-
tial’ analysis).
Steps 1 and 2: thresholds examination and rescoring
Similar ﬁndings were seen here as the above-mentioned analyses.
Eight muscle groups had disordered threshold. For uniformity, all
12 muscle groups were rescored to four response options, thereby
restoring threshold ordering.
Step 3: local dependency and creating subsets
The following steps were driven by the strongest misﬁt seen to the
Rasch model, which was found to be the strong local dependency
ﬁndings of equivalent (right and left) muscle pairs (e.g. shoulder
abductors right and left side; Spearman’s correlations:
 = 0.676–0.831). Therefore, six subsets of items were created,
by combining the corresponding muscle pairs (left and right)
with each other, improving the statistical parameters and resolving
local dependency.
Step 4: unidimensionality examination
Based on the ﬁrst principal components analysis, two comparison
groups of subsets were formed with three positively loaded (arm
muscle subsets) versus three negatively loaded (leg muscle sub-
sets). The independent t-tests between these two groups sug-
gested acceptable unidimensionality [t-test (95% conﬁdence
interval): 0.065 (0.047–0.082)].
Step 5: item bias examination
Uniform differential item functioning was demonstrated on person
factor ‘disease type’ for all created muscle subsets, except for the
elbow ﬂexors subset. Therefore, each subset of muscle pairs was
split in order to obtain speciﬁc subsets for the patients with
Guillain–Barre ´ syndrome and CIDP, separately. After this, the
model was free of any item bias and local dependency. All subsets
of items, except the ‘foot dorsal ﬂexors for patients with Guillain–
Barre ´ syndrome’, demonstrated ﬁt statistics within required limits.
The foot dorsal ﬂexors in Guillain–Barre ´ syndrome had a ﬁt re-
sidual of +5.845 (P = 0.000021), which disturbed Rasch model
ﬁtting (Table 3, ﬁnal analysis for complete model ﬁt after
removing this item). However, for practical reasons the structure
of the MRC sum score (composed by 12 muscles) was maintained,
despite having skewed foot dorsal ﬂexors in the Guillain–Barre ´
syndrome subset of item. A high person separation index (0.91)
was obtained for the ﬁnal modiﬁed MRC sum score model.
Discussion
Manual muscle testing has been used for more than seven dec-
ades for monitoring disease progression and response to therapy in
various neuromuscular disorders (van der Meche and Schmitz,
1992; van der Kooi et al., 1996; de Die-Smulders et al., 1998;
Merkies, 2001; Van den Berg-Vos et al., 2002; van Koningsveld
et al., 2004; Hagemans et al., 2005; Van Asseldonk et al., 2005;
Hughes et al., 2008; Hermans et al., 2010) and the MRC grading
system has been widely used for this purpose (Dyck et al., 2005;
Compston, 2010). This study systematically examined the discrim-
inatory capacity of the MRC grading system in a broad mixture of
patients with neuromuscular illnesses, assessing a large number of
muscles using the Rasch method. The original six response cate-
gories of the MRC grading system failed to differentiate among
patients with various degrees of muscle weakness. Three-quarters
of all muscles examined demonstrated disordered thresholds, es-
pecially in the mid-response categories (options 2–4). The inability
of physicians to apply the apparently intuitive and easily applicable
MRC grades in a proper way is consistent with reports criticizing
the MRC system (Dyck et al., 2005; Schreuders et al., 2006;
MacAvoy and Green, 2007; Merlini, 2010). The current paper
also shows that the observed disordered thresholds were generally
independent of factors such as physicians’ experience, duration of
illness or type of practice (university- versus community-based).
The original MRC grading system inconsistencies were also
‘cross-validated’ throughout the neuromuscular cohorts, as the
ﬁndings between the individual disease cohorts were equivalent.
After systematically rescoring all MRC grades to a modiﬁed four
category response option, the accuracy of the MRC grading
system increased by fulﬁlling ordered thresholds requirements.
While this change from six to four response options might intui-
tively lower the ability to capture functional changes in a patient,
from the current evidence, however, keeping the six responses will
give a false sense of precision and potentially increase the error in
Table 3 Summary Rasch analyses statistics for the modiﬁcation of MRC sum score in patients with GuillainBarre ´
syndrome and CIDP
Analysis Item ﬁt residuals Person ﬁt residuals Item-trait chi-square interaction PSI Unidimensionality
independent
t-test (95%CI)
Mean (SD) Mean (SD) DF P-value
Initial 0.147 (4.626) 0.562 (1.749) 108 50.00001 0.94 0.20 (0.183–0.218)
Final 0.341 (1.100) 0.316 (1.094) 55 0.0891 0.91 NA
In the ﬁnal analysis, item and person ﬁt residuals are acceptable, whereas chi-square is non-signiﬁcant, indicating invariance across the trait. A person separation index
of 0.91 indicates a reliable internal consistency. NA = not available; after performing split analyses, Rasch Unidimensional Measurement Model does not provide the
opportunity to perform unidimensionality testing.
DF = degrees of freedom; PSI = person separation index.
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ful improvement when it may not exist.
The current paper shows the difﬁculties with the use of summed
scores derived from various muscles tested in patients with
Guillain–Barre ´ syndrome and CIDP. However, after Rasch model-
ling, we were able to present a transformed modiﬁed MRC 12
muscle groups summed score for use in future clinical studies in
these disorders (Kleyweg et al., 1991). The analyses revealed
severe misﬁt of the foot dorsal ﬂexors. However, since Guillain–
Barre ´ syndrome and CIDP are length-dependent neuropathies, we
decided to keep this muscle group in the ﬁnal model. The pre-
sented Rasch-built modiﬁed interval MRC sum score is considered
a substantial improvement compared to the evaluation of muscle
strength using ordinal based scores, which in essence are not suit-
able for performing adequate statistics. The modiﬁed interval MRC
sum score for patients with CIDP should, however, be applied
with some caution, because only 139 patients were assessed,
which is lower than the proposed sample size requirements for a
stable model (Linacre, 1994). Also, the responsiveness of the
Rasch-built modiﬁed interval MRC summed score for patients
with Guillain–Barre ´ syndrome and CIDP needs to be demonstrated
in longitudinal studies, which is currently being investigated (Liang,
1995). However, its personal separation index was high, indicating
good ability of the modiﬁed scale to differentiate between groups
of patients with various degrees for muscle weakness. Finally,
since the differential item functioning ﬁndings on diagnosis
(Supplementary Table 3) demonstrate that neuromuscular illnesses
may behave differently, it is conceivable that Rasch-built MRC
sum scores are needed for speciﬁc illnesses such as multifocal
motor neuropathy and other neuromuscular diseases. These efforts
should be the focus of future studies.
In conclusion, the original MRC manual muscle testing grading
system failed to meet the Rasch model expectations in various
neuromuscular disorders, despite being the standard metric in
neurology worldwide. Modiﬁcation of this grading system to
four response categories (0, paralysis; 1, severe weakness; 2,
slight weakness; and 3, normal strength) may signiﬁcantly en-
hance the ability of clinicians to differentiate degrees of weakness
with greater precision and accuracy. Based on this, we have de-
veloped a Rasch-built interval MRC summed score for use in
future clinical studies evaluating patients with Guillain–Barre ´ syn-
drome and CIDP. Future studies are warranted to improve the
solidness of our neurological assessments.
Supplementary Material
Supplementary material is available at Brain online.
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